Marten J. Poley - Erasmus Universiteit Rotterdam

General Discussion: A Guided Tour Providing Four Different Views of the Results 13920. Zwart-van Rijkom JEF, Leufkens HGM,Busschbach JJV, Broekmans AW, RuttenFFH: Differences in attitudes, knowledgeand use of economic evaluations indecision-making in The Netherlands. TheDutch results from the EUROMETProject. Pharmacoeconomics 2000;18(2): 149-160.21. Stolk EA, Post HA, Rutten FFH, MolenaarJC, Busschbach JJV: Cost-effectivenessof neonatal surgery: a review. J PediatrSurg 2000; 35(4): 588-592.22. Doyle NM, Lally KP: The CDH StudyGroup and advances in the clinical careof the patient with congenitaldiaphragmatic hernia. Semin Perinatol2004; 28(3): 174-184.23. Hout BAv: Whom and how to treat:weighing the costs and effects. Scand JGastroenterol Suppl 2003; (239): 3-10.24. Nyman JA: Should the consumption ofsurvivors be included as a cost in costutilityanalysis? Health Econ 2004;13(5): 417-427.25. Ramsey S, Willke R, Briggs A, Brown R,Buxton M, Chawla A, et al: Goodresearch practices for cost-effectivenessanalysis alongside clinical trials: theISPOR RCT-CEA task force report. ValueHealth 2005; 8(5): 521-533.26. Ungar WJ, Santos MT: The PediatricQuality Appraisal Questionnaire: aninstrument for evaluation of the pediatrichealth economics literature. ValueHealth 2003; 6(5): 584-594.27. Ungar WJ, Santos MT: Quality appraisalof pediatric health economic evaluations.Int J Technol Assess Health Care 2005;21(2): 203-210.28. De Civita M, Regier D, Alamgir AH, AnisAH, Fitzgerald MJ, Marra CA: Evaluatinghealth-related quality-of-life studies inpaediatric populations: some conceptual,methodological and developmentalconsiderations and recent applications.Pharmacoeconomics 2005; 23(7): 659-685.29. Griebsch I, Coast J, Brown J: Qualityadjustedlife-years lack quality inpediatric care: a critical review ofpublished cost-utility studies in childhealth. Pediatrics 2005; 115(5): e600-e614.30. Petrou S: Methodological issues raisedby preference-based approaches tomeasuring the health status of children.Health Econ 2003; 12(8): 697-702.31. Petrou S, Henderson J: Preference-basedapproaches to measuring the benefits ofperinatal care. Birth 2003; 30(4): 217-226.32. Feeny D, Furlong W, Boyle M, TorranceGW: Multi-attribute health statusclassification systems. Health UtilitiesIndex. Pharmacoeconomics 1995; 7(6):490-502.33. The EuroQol Group: EuroQol - a newfacility for the measurement of healthrelatedquality of life. Health Policy1990; 16(3): 199-208.34. Basu A, Meltzer D: Implications ofspillover effects within the family formedical cost-effectiveness analysis. JHealth Econ 2005; 24(4): 751-773.35. Christakis NA, Iwashyna TJ: The healthimpact of health care on families: amatched cohort study of hospice use bydecedents and mortality outcomes insurviving, widowed spouses. Soc Sci Med2003; 57(3): 465-475.36. Jacobsson F, Carstensen J, Borgquist L:Caring externalities in health economicevaluation: how are they related toseverity of illness? Health Policy 2005;73(2): 172-182.37. Keren R, Pati S, Feudtner C: Thegeneration gap: differences betweenchildren and adults pertinent toeconomic evaluations of healthinterventions. Pharmacoeconomics2004; 22(2): 71-81.